Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives
Background and purpose: Liver fibrosis, a progressive liver disease arising from viral or metabolic causes, poses a major global health challenge due to its potential progression to cirrhosis and hepatocellular carcinoma. Due to the complex aetiology and epidemiology of liver fibrosis, most therapi...
Saved in:
| Main Authors: | Alka Singh, Ansab Akhtar, Prashant Shukla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Association of Physical Chemists (IAPC)
2025-08-01
|
| Series: | ADMET and DMPK |
| Subjects: | |
| Online Access: | https://pub.iapchem.org/ojs/index.php/admet/article/view/2874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential
by: Renjie Xu, et al.
Published: (2024-10-01) -
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
by: Muhammad Mazhar Azam, et al.
Published: (2024-12-01) -
Resmetirom and Thyroid Hormone Receptor‐Targeted Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD)
by: Chang‐Hai Liu, et al.
Published: (2025-03-01) -
Significant Within-Individual Variability in VCTE Liver Stiffness Measurements at Two Intercostal Spaces in Subjects with MASLD: Implications for Evaluating Improvement in Liver Fibrosis After Weight-Loss or Liver-Directed Therapy
by: Jordan S. Woodard, et al.
Published: (2024-11-01) -
Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment
by: Hashim Talib Hashim, et al.
Published: (2024-10-01)